News on iCo Therapeutics Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated iCo Therapeutics Inc. news from BioPortfolio.com Wed, 10 Feb 2010 13:30:56 GMT en Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994253&HITNO=0&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994253&THISHREF=http://c.moreover.com/click/here.pl%3fz2514944411%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994253&HITNO=0&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994253&THISHREF=http://c.moreover.com/click/here.pl%3fz2514944411%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988008&HITNO=1&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988008&THISHREF=http://c.moreover.com/click/here.pl%3fz2510384418%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988008&HITNO=1&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988008&THISHREF=http://c.moreover.com/click/here.pl%3fz2510384418%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985650&HITNO=2&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985650&THISHREF=http://c.moreover.com/click/here.pl%3fz2508723855%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985650&HITNO=2&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985650&THISHREF=http://c.moreover.com/click/here.pl%3fz2508723855%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984918&HITNO=3&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984918&THISHREF=http://c.moreover.com/click/here.pl%3fz2508401838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984918&HITNO=3&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984918&THISHREF=http://c.moreover.com/click/here.pl%3fz2508401838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobe Investor: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985739&HITNO=4&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985739&THISHREF=http://c.moreover.com/click/here.pl%3fz2508792955%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985739&HITNO=4&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985739&THISHREF=http://c.moreover.com/click/here.pl%3fz2508792955%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockhouse Canada: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985581&HITNO=5&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985581&THISHREF=http://c.moreover.com/click/here.pl%3fz2508670415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985581&HITNO=5&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985581&THISHREF=http://c.moreover.com/click/here.pl%3fz2508670415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNW Telbec: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985233&HITNO=6&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985233&THISHREF=http://c.moreover.com/click/here.pl%3fz2508520543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985233&HITNO=6&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985233&THISHREF=http://c.moreover.com/click/here.pl%3fz2508520543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984920&HITNO=7&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984920&THISHREF=http://c.moreover.com/click/here.pl%3fz2508402613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984920&HITNO=7&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984920&THISHREF=http://c.moreover.com/click/here.pl%3fz2508402613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984916&HITNO=8&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984916&THISHREF=http://c.moreover.com/click/here.pl%3fz2508401496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984916&HITNO=8&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984916&THISHREF=http://c.moreover.com/click/here.pl%3fz2508401496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Isis Pharmaceuticals Exercises Warrants of iCo Therapeutics Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984833&HITNO=9&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984833&THISHREF=http://c.moreover.com/click/here.pl%3fz2508373761%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984833&HITNO=9&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984833&THISHREF=http://c.moreover.com/click/here.pl%3fz2508373761%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCanada NewsWire: Erbitux improves survival of mCRC patients with KRAS wild-type tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955158&HITNO=10&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955158&THISHREF=http://c.moreover.com/click/here.pl%3fz2493791952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955158&HITNO=10&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955158&THISHREF=http://c.moreover.com/click/here.pl%3fz2493791952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: CDC FluView reporthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3849982&HITNO=11&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3849982&THISHREF=http://c.moreover.com/click/here.pl%3fz2439338245%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3849982&HITNO=11&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3849982&THISHREF=http://c.moreover.com/click/here.pl%3fz2439338245%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCenter for Disease Control and Prevention: iCo Therapeutics Grants Options to Directors, Officers and Employeeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3847937&HITNO=12&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3847937&THISHREF=http://c.moreover.com/click/here.pl%3fz2436617197%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3847937&HITNO=12&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3847937&THISHREF=http://c.moreover.com/click/here.pl%3fz2436617197%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: iCo Therapeutics Provides Phase 1 Diabetic Macular Edema (DME) Clinical Trial Update and Phase 2 Trial Guidanchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3771211&HITNO=13&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3771211&THISHREF=http://c.moreover.com/click/here.pl%3fz2395464062%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3771211&HITNO=13&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3771211&THISHREF=http://c.moreover.com/click/here.pl%3fz2395464062%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: iCo Therapeutics iCo-007 Overview to be Presented at the 8th International Symposium on Ocular Pharmacology anhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3729900&HITNO=14&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3729900&THISHREF=http://c.moreover.com/click/here.pl%3fz2376813340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3729900&HITNO=14&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=iCo%20Therapeutics%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3729900&THISHREF=http://c.moreover.com/click/here.pl%3fz2376813340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: